Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Encompass Health Corporation stock logo
EHC
Encompass Health
$109.95
+2.5%
$119.45
$82.74
$123.13
$10.81B0.88728,762 shs1.87 million shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$51.75
+2.6%
$53.89
$13.47
$72.98
$11.29B2.0224.06 million shs22.06 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$314.83
+0.7%
$306.48
$250.05
$459.77
$8.99B1.47379,165 shs324,337 shs
ResMed Inc. stock logo
RMD
ResMed
$254.00
+0.8%
$250.83
$196.43
$263.05
$36.95B0.77743,524 shs829,576 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Encompass Health Corporation stock logo
EHC
Encompass Health
-10.57%-9.37%-11.43%+3.71%+25.16%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-2.95%+3.03%-8.83%+87.38%+120.85%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-2.39%-3.04%+4.85%+5.47%-29.65%
ResMed Inc. stock logo
RMD
ResMed
-0.83%-1.84%+1.13%+18.98%+22.73%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Encompass Health Corporation stock logo
EHC
Encompass Health
4.9266 of 5 stars
3.63.01.75.02.62.52.5
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.2371 of 5 stars
2.02.00.00.02.43.31.9
Medpace Holdings, Inc. stock logo
MEDP
Medpace
3.736 of 5 stars
1.11.00.04.62.24.22.5
ResMed Inc. stock logo
RMD
ResMed
4.4255 of 5 stars
2.40.03.34.64.11.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Encompass Health Corporation stock logo
EHC
Encompass Health
3.14
Buy$131.5019.60% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1.92
Reduce$39.58-23.51% Downside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.21
Hold$344.829.53% Upside
ResMed Inc. stock logo
RMD
ResMed
2.73
Moderate Buy$263.003.54% Upside

Current Analyst Ratings Breakdown

Latest RMD, MEDP, EHC, and HIMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
ResMed Inc. stock logo
RMD
ResMed
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$250.00 ➝ $270.00
7/15/2025
ResMed Inc. stock logo
RMD
ResMed
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform$255.00 ➝ $294.00
6/24/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$45.00
6/24/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Equal Weight$300.00
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$30.00
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
6/11/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$40.00
6/5/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOverweight ➝ Strong-Buy$135.00
6/4/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$61.00 ➝ $65.00
(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Encompass Health Corporation stock logo
EHC
Encompass Health
$5.37B2.06$7.75 per share14.19$27.72 per share3.97
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$1.48B7.85$0.36 per share143.29$2.16 per share23.96
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.11B4.29$14.05 per share22.41$26.56 per share11.85
ResMed Inc. stock logo
RMD
ResMed
$4.69B7.95$9.30 per share27.31$33.11 per share7.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Encompass Health Corporation stock logo
EHC
Encompass Health
$455.70M$4.8422.9220.822.188.97%17.63%7.33%8/4/2025 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$126.04M$0.69117.3599.521.869.24%22.75%15.51%8/4/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.1023.8723.055.6619.31%54.36%20.81%7/21/2025 (Confirmed)
ResMed Inc. stock logo
RMD
ResMed
$1.02B$8.9127.7524.521.5826.15%25.67%18.59%7/31/2025 (Estimated)

Latest RMD, MEDP, EHC, and HIMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.20N/AN/AN/A$1.43 billionN/A
8/4/2025Q2 2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.17N/AN/AN/A$550.06 millionN/A
7/31/2025Q4 2025
ResMed Inc. stock logo
RMD
ResMed
$2.47N/AN/AN/A$1.33 billionN/A
7/21/2025Q2 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.01N/AN/AN/A$537.70 millionN/A
5/5/2025Q1 2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.12$0.20+$0.08$0.20$535.21 million$586.01 million
4/24/2025Q1 2025
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.19$1.37+$0.18$1.48$1.43 billion$1.46 billion
4/23/2025Q3 2025
ResMed Inc. stock logo
RMD
ResMed
$2.36$2.37+$0.01$2.48$1.28 billion$1.29 billion
4/21/2025Q1 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.06$3.67+$0.61$3.67$528.38 million$558.57 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Encompass Health Corporation stock logo
EHC
Encompass Health
$0.680.62%N/A14.05%2 Years
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.120.83%N/A23.79%13 Years

Latest RMD, MEDP, EHC, and HIMS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.170.59%7/1/20257/1/20257/15/2025
4/24/2025
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.530.9%5/8/20255/8/20256/12/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Encompass Health Corporation stock logo
EHC
Encompass Health
0.81
1.06
1.06
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/A
1.59
1.32
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
ResMed Inc. stock logo
RMD
ResMed
0.12
3.41
2.49

Institutional Ownership

CompanyInstitutional Ownership
Encompass Health Corporation stock logo
EHC
Encompass Health
97.25%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Encompass Health Corporation stock logo
EHC
Encompass Health
2.00%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
13.71%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
ResMed Inc. stock logo
RMD
ResMed
0.71%
CompanyEmployeesShares OutstandingFree FloatOptionable
Encompass Health Corporation stock logo
EHC
Encompass Health
40,000100.80 million98.78 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,637223.83 million193.15 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90028.74 million22.91 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
9,980146.63 million145.59 millionOptionable

Recent News About These Companies

ResMed Inc. (NYSE:RMD) Shares Sold by Stephens Inc. AR
ResMed Inc. (NYSE:RMD) Stake Reduced by M&T Bank Corp

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Encompass Health stock logo

Encompass Health NYSE:EHC

$109.95 +2.67 (+2.49%)
Closing price 03:59 PM Eastern
Extended Trading
$111.00 +1.05 (+0.95%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$51.75 +1.29 (+2.56%)
Closing price 03:59 PM Eastern
Extended Trading
$51.50 -0.25 (-0.49%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Medpace stock logo

Medpace NASDAQ:MEDP

$314.83 +2.12 (+0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$315.15 +0.32 (+0.10%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

ResMed stock logo

ResMed NYSE:RMD

$254.00 +1.99 (+0.79%)
Closing price 03:59 PM Eastern
Extended Trading
$254.16 +0.15 (+0.06%)
As of 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.